Anti-glycative and anti-inflammatory effects of caffeic acid and ellagic acid in kidney of diabetic mice

Molecular Nutrition and Food Research

Volumn 54, Issue 3, 2010, Pages 388-395

  Chao, Che Yi ^a   Mong, Mei Chin ^a   Chan, Kung Chi ^b   Yin, Mei Chin ^c  

^a ASIA UNIVERSITY   (Taiwan)

^b PROVIDENCE UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Aldose reductase; Diabetes; Glycation; Monocyte chemoattractant protein 1; Tumor necrosis factor

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALDEHYDE REDUCTASE; BIOLOGICAL MARKER; CAFFEIC ACID DERIVATIVE; CYTOKINE; ELLAGIC ACID; FRUCTOSE; IDITOL DEHYDROGENASE; MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT; SORBITOL;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BLOOD; DIABETIC NEPHROPATHY; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION REGULATION; GENETICS; GLYCOSYLATION; KIDNEY; KIDNEY FUNCTION TEST; MALE; METABOLISM; MOUSE; PATHOPHYSIOLOGY; TIME;

ALDEHYDE REDUCTASE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL MARKERS; CAFFEIC ACIDS; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; ELLAGIC ACID; FRUCTOSE; GENE EXPRESSION REGULATION; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; KIDNEY; KIDNEY FUNCTION TESTS; L-IDITOL 2-DEHYDROGENASE; MALE; MICE; MICE, INBRED BALB C; RNA, MESSENGER; SORBITOL; TIME FACTORS;

MUS;

EID: 77649285638     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200900087     Document Type: Article

References (31)

1. Ziyadeh, F. N., Mogyorosi, A., Kalluri, R., Early and advanced non-enzymatic glycation products in the pathogenesis of diabetic kidney disease. Exp. Nephrol. 1997, 5, 2-9.
2. Dunlop, M., Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int. 2000, 58, 3-12.
3. Gugliucci, A., Bendayan, M., Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells. Diabetologia 1997, 39, 149-160.
4. Geerlings, S. E., Brouwer, E. C., van Kessel, K. C., Gaastra, W. et al., Cytokine secretion is impaired in women with diabetes mellitus. Eur. J. Clin. Investig. 2000, 30, 995-1001.
5. Aso, Y., Okumura, K., Yoshida, N., Tayama, K. et al., Plasma interleukin-6 is associated with coagulation in poorly controlled patients with Type 2 diabetes. Diab. Med. 2003, 20,930-934.
6. Dan, Q., Wong, R. L. C., Yin, S., Chung, S. K. et al., Interaction between the polyol pathway and non-enzymatic glycation on mesangial cell gene expression. Nephron Exp. Nephrol. 2004, 98, 89-99.
7. Cheung, A. K., Fung, M. K., Lo, A. C., Lam, T. T. et al., Aldose reductase deficiency prevents diabetes-induced blood--retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice. Diabetes 2005, 54, 3119-3125.
8. Maekawa, K., Tanimoto, T., Okada, S., Suzuki, T. et al., Expression of aldose reductase and sorbitol dehydrogenase genes in Schwann cells isolated from rat: effects of high glucose and osmotic stress. Brain Res. Mol. Brain Res. 2001, 87,251-256.
9. Mizisin, A. P., Li, L., Perello, M., Freshwater, J. D. et al., Polyol pathway and osmoregulation in JS1 Schwann cells grown in hyperglycemic and hyperosmotic conditions. Am. J. Physiol. 1996, 270, 90-97.
10. Sellappan, S., Akoh, C. C., Krewer, G., Phenolic compounds and antioxidant capacity of Georgia-grown blueberries and blackberries. J. Agric. Food Chem. 2002, 50, 2432-2438.
11. Mattila, P., Kumpulainen, J., Determination of free and total phenolic acids in plant-derived foods by HPLC with diode-array detection. J. Agric. Food Chem. 2002, 50, 3660-3667.
12. Makena, P. S., Chung, K. T., Effects of various plant polyphenols on bladder carcinogen benzidine-induced mutagenicity. Food Chem. Toxicol. 2007, 45, 1899-1909.
13. Prakash, D., Suri, S., Upadhyay, G., Singh, B. N., Total phenol, antioxidant and free radical scavenging activities of some medicinal plants. Int. J. Food Sci. Nutr. 2007, 58, 18-28.
14. Jung, U. J., Lee, M. K., Park, Y. B., Jeon, S. M. et al., Antihyperglycemic and antioxidant properties of caffeic acid in db/db mice. J. Pharmacol. Exp. Ther. 2006, 318, 476-483.
15. Ueda, H., Kawanishi, K., Moriyasu, M., Effects of ellagic acid and 2-(2,3,6-trihydroxy-4-carboxyphenyl)ellagic acid on sorbitol accumulation in vitro and in vivo. Biol. Pharm. Bull. 2004,27,1584-1587.
16. Lowry, O. H., Rosebrough, N. J., Farr, A. L., Protein determination with the Folin phenol reagent. J. Biol. Chem. 1951, 193,265-275.
17. Seeram, N. P., Aronson, W. J., Zhang, Y., Henning, S. M. et al., Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland. J. Agric. Food Chem. 2007, 55, 7732-7737.
18. Inagi, R., Yamamoto, Y., Nangaku, M., Usuda, N. et al., A severe diabetic nephropathy model with early development of nodule-like lesions induced by megsin over-expression in RAGE/iNOS transgenic mice. Diabetes 2006, 55,356-366.
19. Miyata, T., Taneda, S., Kawai, R., Ueda, Y. et al., Identification of pentosidine as a native structure for advanced glycation end products in b2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis. Proc. Natl. Acad. Sci. USA 1996, 93, 2353-2358.
20. Guerrant, G., Moss, C. W., Determination of monosaccharides as aldononitrile, O-methyoxime, alditol, and cyclitol acetate derivatives by gas chromatography. Anal. Chem. 1984, 56, 633-638.
21. Nishinaka, T., Yabe-Nishimura, C., EGF receptor-ERK pathway is the major signaling pathway that mediates upregulation of aldose reductase expression under oxidative stress. Free Radic. Biol. Med. 2001, 31, 205-216.
22. nd Edn., Verlag Chemie, Weinheim 1974, pp. 569-573.
23. Peppa, M., Uribarri, J., Vlassara, H., Aging and glycoxidant stress. Hormones 2008, 7, 123-132.
24. Takeuchi, M., Yamagishi, S., Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease. Curr. Pharm. Des. 2008, 14, 973-978.
25. Lee, Y. S., Kang, Y. H., Jung, J. Y., Kang, I. J. et al., Inhibitory constitutents of aldose reductase in the fruiting body of Phellinus linteus. Biol. Pharm. Bull. 2008, 31, 765-768.
26. Mohamed-Ali, V., Armstrong, L., Vlark, D., Bolton, C. H. et al., Evidence for the regulation of levels of plasma adhesion molecules by inflammatory cytokines and their soluble receptors in type 1 diabetes. J. Intern. Med. 2001, 250, 415-421.
27. Tomita, M., Dragoman, M., Worcester, H., Conran, P. et al., Proinflammatory cytokine genes are constitutively over-expressed in the heart in experimental systemic lupus erythematosus: a brief communication. Exp. Biol. Med. 2004,229,971-976.
28. Takahashi, K., Mizuarai, S., Araki, H., Mashiko, S. et al., Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice. J. Biol. Chem. 2003,278,46654-46660.
29. Martinovic, I., Abegunewardene, N., Seul, M., Vosseler, M. et al., Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease. Circ. J. 2005,69,1484-1489.
30. Rashid, G., Benchetrit, S., Fishman, D., Bernheim, J., Effect of advanced glycation end-products on gene expression and synthesis of TNF-alpha and endothelial nitric oxide synthase by endothelial cells. Kidney Int. 2004, 66, 1099-1106.
31. Dronavalli, S., Duka, I., Bakris, G. L., The pathogenesis of diabetic nephropathy. Nat. Clin. Pract. Endocrinol. Metab. 2008,4,444-452.